Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab
β Scribed by K. A. Toulis; A. D. Anastasilakis
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 60 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Denosumab reduces the risk of new vertebral and nonvertebral fractures. Previous trials suggest that the efficacy of antiresorptives on fractures might differ by patients' characteristics, such as age, bone mineral density (BMD), and fracture history. In the FREEDOM study, 7808 women ag
We assessed the association between different HPV genotypes, HIV infection, and cervical squamous intra-epithelial lesions (SIL) in 236 women with known HIV serostatus enrolled in a longitudinal multicentric study in Italy. Of these women, 135 were HIV-infected, and were not markedly different from